LISATA THERAPEUTICS, INC. Accrued Liabilities
LISATA THERAPEUTICS, INC. (LSTA) had Accrued Liabilities of $4.17 million as of 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Balance Sheet › Liabilities › Accounts Payable and Accrued Liabilities › Accrued Liabilities
us-gaap:AccruedLiabilitiesCurrentAndNoncurrent · last filed 2024-02-29
- 2023-12-31: Accrued Liabilities $4.17M.
- 2022-12-31: Accrued Liabilities $3.73M.
- 2021-12-31: Accrued Liabilities $2.59M.
- 2020-12-31: Accrued Liabilities $2.49M.
| Period end | Accrued Liabilities | Accrued Liabilities as first filed |
|---|---|---|
| 2023-12-31 | $4.17M 10-K · filed 2024-02-29 | |
| 2022-12-31 | $3.73M 10-K · filed 2024-02-29 | |
| 2021-12-31 | $2.59M 10-K · filed 2023-03-30 | |
| 2020-12-31 | $2.49M 10-K · filed 2022-03-22 | |
| 2019-12-31 | $4.49M 10-K · filed 2021-02-25 | |
| 2019-06-30 | $5.15M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $4.55M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $4.86M 10-K · filed 2020-03-05 | |
| 2018-09-30 | $4.45M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $5.30M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $7.00M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $7.81M 10-K · filed 2019-03-14 | $7.81M 10-K · filed 2018-03-22 |
| 2017-09-30 | $10.14M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $12.41M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $5.06M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $2.66M 10-K · filed 2018-03-22 | $6.06M 10-K · filed 2017-03-17 |
| 2016-09-30 | $6.37M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $6.20M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $6.32M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $6.20M 10-K · filed 2017-03-17 | $6.20K 10-K · filed 2016-03-15 |
| 2015-09-30 | $8.01M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $7.18M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $5.72M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $4.32K 10-K · filed 2016-03-15 | |
| 2014-09-30 | $2.82M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $2.59K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $2.38K 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $4.02K 10-K · filed 2015-03-02 | |
| 2013-09-30 | $2.23K 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $1.99K 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $1.68K 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $2.28K 10-K · filed 2014-03-13 | |
| 2011-12-31 | $1.09K 10-K · filed 2013-03-11 | $1.09M 8-K · filed 2012-08-15 |
| 2010-12-31 | $720.40K 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |